TGFB1 and neoplasm: The scRNA-seq data suggested that the enhanced expression of chemokines in tumors treated with anti-PD-L1 plus anti-TGF-β may contribute to the ability of anti-TGF-β to enhance the anti-tumor efficacy of anti-PD-L1.